Parents should be alarmed by unsatisfactory ponderal gain, cyanosis (permanent or due to the effort of feeding), profuse perspiration, apathy, fast or difficult breathing, persistent wheezing or coughing in the supine position. Infants may sleep more than normal and have diminished activity in general [1].

A particular problem is represented by tet spells. These appear in children with cyanotic CHD such as tetralogy of Fallot, severe pulmonary stenosis or atresia or other decreased pulmonary blood flow malformations. Tet spells consist of inconsolable crying with increasing cyanosis and hyperpnoea and may lead to the loss of consciousness and even death. Older children instinctively adopt a squatting position, thus increasing systemic vascular resistance and blood flow to the lungs [2].

Blood saturation may differ in different regions of the body, so upper extremities may be more pink than lower extremities (differential cyanosis, found in patent ductus arteriosus with pulmonary hypertension or preductal coarctation of the aorta associated with patent ductus arteriosus ) or more bluish than the lower extremities (reversed differential cyanosis, found in transposition of the great arteries with patent ductus arteriosus and elevated pulmonary vascular resistance or in TGA with PDA and preductal aortic interruption or coarctation [3].

Presentation of children with ductal-dependent CHD dramatically changes as the ductus arteriosus changes. Thus, symptoms depend on whether the pulmonary circulation or the systemic circulation depend on the patency of the ductus arteriosus.

The clinician should take a short history about the presence of CHD or sudden death in other family members. Inspection and palpation may reveal a hyperactive precordium, dextrocardia, heart enlargement or thrill. The heart impulse might be displaced (if the right ventricle is overloaded) or prominent (when the left ventricle has a pressure or volume overload). Auscultation findings may include tachycardic or bradycardic sounds;
heart murmurs- their location, intensity, musical qualities and lack of variability with respiratory movements may suggest the underlying defect; paradoxically or fixed split, single or inaudible sounds: S2 may be single in conditions associated with pulmonary hypertension or great vessels valve abnormalities: aortic or pulmonary atresia or severe stenosis or truncus arteriosus; abnormal supplementary heart sounds: early systolic (aortic or pulmonary stenosis) or mid systolic clicks (mitral valve prolapse, Ebstein’s anomaly), atrial or ventricular gallop may also occur. Pericardial friction rubs suggest pericarditis, while murmurs may be absent in the presence of severe ventricular dysfunction or pulmonary hypertension [4] [5] [6].
Liver enlargement should also be evaluated, keeping in mind that the inferior edge is normally felt 1-3 cm below the rib cage in newborns. The symmetry and amplitude of pulses should be routinely observed, in order not to miss associated abnormalities such as coarctation of the aorta or interrupted aortic arch.

Numerous professional cardiology associations recommend routine pulse oximetry newborn screening. The sensor should be placed on the right hand (to measure preductal saturation) or the foot (to measure postductal saturation) [7] [8] [9] [10] [11] [12].

An electrocardiogram may be normal or may show arrhythmia or congenital heart block, bundle branch blocks or cavity enlargement.

Thoracic radiography should be used to evaluate the location of the heart, vascular pulmonary markings, and cardiac silhouette: "boot" shape in tetralogy of Fallot, "egg-on-string" in transposition of great arteries, or "snowman" in total anomalous pulmonary venous return.

Echocardiography is performed in patients with signs of cardiogenic shock or abnormal findings on the ECG or thoracic radiography. Echocardiography is able to accurately measure cavities and walls, pressure gradients and velocities, and describe defects or exclude CHD as the cause of cyanosis.

If doubt arises from echocardiographic studies or if symptoms do not match echocardiographic data, cardiac computer tomography and magnetic resonance might be useful. However, these are not available in all centers, especially in underdeveloped countries. In this situation and in cases where it is necessary to measure pulmonary vascular resistance to determine if surgery is appropriate, cardiac catheterization is indicated. However, given that this method involves radiation exposure, it should only be used in cases where cardiac anatomy or function is not properly defined by less invasive methods, such as low flow lesions that make pulmonary resistance calculation difficult [13].

Treatment for CCHD depends on the specific type and severity of the heart defect. In many cases, surgical intervention is required to correct the defect and improve blood flow. This may involve procedures such as shunt placement, valve repair or replacement, or complex reconstructive surgeries. In some cases, medication may be prescribed to manage symptoms and improve heart function. Long-term follow-up care is essential to monitor the patient's condition and address any complications that may arise.

The prognosis for individuals with CCHD varies widely depending on the specific heart defect, the timing and success of treatment, and the presence of any associated conditions. Advances in surgical techniques and medical care have significantly improved outcomes for many patients. However, some individuals may experience ongoing health challenges and require lifelong medical care. Early diagnosis and appropriate treatment are crucial for improving the prognosis and quality of life for patients with CCHD.

CCHD is caused by structural abnormalities in the heart that develop during fetal development. The exact cause of these abnormalities is often unknown, but a combination of genetic and environmental factors is believed to play a role. Some cases are associated with genetic syndromes or chromosomal abnormalities, while others may be linked to maternal factors such as infections, diabetes, or exposure to certain medications or substances during pregnancy.

CCHD is one of the most common types of congenital heart defects, affecting approximately 1 in 1,000 live births. It accounts for a significant proportion of infant morbidity and mortality related to congenital heart disease. The incidence of CCHD varies by geographic region and population, with certain genetic and environmental factors influencing its prevalence.

The pathophysiology of CCHD involves abnormal blood flow patterns within the heart and great vessels, leading to the mixing of oxygen-rich and oxygen-poor blood. This results in reduced oxygen delivery to the body's tissues, causing cyanosis. The specific pathophysiological mechanisms depend on the type of heart defect, such as Tetralogy of Fallot, transposition of the great arteries, or truncus arteriosus, each of which affects the heart's structure and function differently.

While not all cases of CCHD can be prevented, certain measures may reduce the risk. These include maintaining good maternal health, managing chronic conditions such as diabetes, avoiding harmful substances during pregnancy, and ensuring adequate prenatal care. Genetic counseling may be recommended for families with a history of congenital heart defects to assess the risk of recurrence in future pregnancies.

Cyanotic Congenital Heart Disease is a serious condition characterized by low oxygen levels in the blood due to structural heart defects present at birth. It requires prompt diagnosis and often surgical intervention to improve outcomes. While the exact cause is often unknown, a combination of genetic and environmental factors is believed to contribute to its development. Advances in medical care have improved the prognosis for many patients, but ongoing management and follow-up care are essential.

If you or your child has been diagnosed with Cyanotic Congenital Heart Disease, it's important to understand the nature of the condition and the treatment options available. CCHD is a group of heart defects that affect how blood flows through the heart and lungs, leading to low oxygen levels in the blood. This can cause symptoms like a bluish tint to the skin, difficulty breathing, and fatigue. Treatment often involves surgery to correct the heart defect and improve blood flow. With advances in medical care, many individuals with CCHD can lead healthy lives, but ongoing medical follow-up is important to monitor the condition and manage any complications.

1. Aisenberg RB, Rosenthal A, Nadas AS, Wolff PH. Developmental delay in infants with congenital heart disease. Correlation with hypoxemia and congestive heart failure. Pediatr Cardiol 1982; 3:133.
2. Park MK. Pediatric cardiology for Practitioners.4th end. Mosey, St. Louis. 2004; 123
3. Yap SH, Anania N, Alboliras ET, Lilien LD. Reversed differential cyanosis in the newborn: a clinical finding in the supracardiac total anomalous pulmonary venous connection. Pediatr Cardiol. 2009 Apr;30(3):359-62
4. Rein AJ, Omokhodion SI, Nir A. Significance of a cardiac murmur as the sole clinical sign in the newborn. Clin Pediatr (Phila). 2000; 39:511.
5. Hansen LK, Birkebaek NH, Oxhøj H. Initial evaluation of children with heart murmurs by the non-specialized paediatrician. Eur J Pediatr. 1995; 154:15.
6. McCrindle BW, Shaffer KM, Kan JS, et al. Cardinal clinical signs in the differentiation of heart murmurs in children. Arch Pediatr Adolesc Med. 1996; 150:169.
7. de-Wahl Granelli A, Wennergren M, Sandberg K, et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ. 2009; 338:a3037.
8. Meberg A, Brügmann-Pieper S, Due R Jr, et al. First day of life pulse oximetry screening to detect congenital heart defects. J Pediatr. 2008; 152:761.
9. Riede FT, Wörner C, Dähnert I, et al. Effectiveness of neonatal pulse oximetry screening for detection of critical congenital heart disease in daily clinical routine--results from a prospective multicenter study. Eur J Pediatr. 2010; 169:975.
10. Ewer AK, Middleton LJ, Furmston AT, et al. Pulse oximetry screening for congenital heart defects in newborn infants (PulseOx): a test accuracy study. Lancet. 2011; 378:785.
11. Thangaratinam S, Brown K, Zamora J, et al. Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis. Lancet. 2012; 379:2459.
12. Ewer AK, Furmston AT, Middleton LJ, et al. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness. Health Technol Assess 2012; 16:v.
13. Feltes T, Bacha E, Beekman R, et al. Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease. A Scientific Statement From the American Heart Association. Circulation. 2011;123:2607-2652